Objectives: We investigated the prevalence and long-term risk associated with intracranial atherosclerosis identified during routine evaluation.
Article Focus:
• Establishing the incidence of intracranial arterial stenosis and calcifications in an acute stroke population.
• Identifying potential modifiable risk factors for intracranial atherosclerosis.
• Assessing if intracranial atherosclerosis identified during acute stroke evaluation could predict poor long-term outcome.
Key Messages:
• Radiological markers of intracranial atherosclerosis are prevalent in North European patients with symptoms of acute stroke or TIA.
• Intracranial atherosclerosis is linked to atherosclerotic disease in other extracranial vascular beds.
• Intracranial artery stenosis or calcifications independently increase the risk of recurrent ischemic event.
Strengths and Limitations of this Study:
• The primary strength is the high degree of generalizability due to the unselected patient population.
• Another important strength of this study was the consistent use of CT-angiography.
• Limitations include the acute CTA performance that might lead to an underestimation of the true prevalence of intracranial arterial stenosis due to thrombus formation. 
INTRODUCTION:
Ischemic stroke remains a leading cause of disability and death worldwide, and one of six persons suffers a stroke during their lifetime. Intracranial atherosclerosis represents a risk factor of stroke, however, varying incidence and significance worldwide have been reported [1] [2] [3] [4] [5] [6] . Even though intracranial artery atherosclerosis is traditionally assumed most prevalent in patients of Asian descent, limited evidence is available as to the prevalence and prognostic significance of intracranial atherosclerosis in a European stroke population.
Overall, two markers of intracranial atherosclerotic changes are recognized on CT-based imaging of stroke patients: intracranial arterial stenosis (IAS) and diffuse intracranial arterial calcifications (IAC).
IAS has in recent years received much attention in relation to possible treatment interventions especially with regard to endovascular procedures [7] and pharmacological treatment [8] . Though most attention has been focused on stenosis with severe lumen reduction, post mortem studies have
shown that even lumen reductions of 30% can potentially give rise to embolism or thrombus [9] .
This finding indicates that patients with 30% stenosis could potentially be at increased risk of recurrent stroke.
IAC is assumed to reflect the atherosclerotic burden and can be assessed by means of simple noncontrast CT [10, 11] . Even though these lesions do not necessarily cause lumen reduction and may represent a more diffuse atherosclerotic process -limited evidence suggests their link to recurrent ischemic event in stroke patients [12] . Because intracranial atherosclerosis may represent an important and potentially modifiable risk factor for recurrent ischemic event in an European stroke population, we aimed at: (1) establishing the incidence of intracranial arterial stenosis and calcifications in an acute Northern European thrombolysis population identified during acute radiological examination; (2) identifying potential modifiable risk-factors; and (3) assessing whether intracranial atherosclerosis identified during acute stroke evaluation predicts poor long-term outcome.
METHODS:
This study is based on a prospective cohort of stroke or TIA (transitory ischemic stroke) patients admitted to Copenhagen University Hospital -Bispebjerg with symptoms of acute stroke within 4.5 hours and worked up for recanalization therapy. The hospital has a catchment area for acute stoke of 1.7 mill inhabitants on even dates, sharing the function with another hospital.
Patients admitted from April 2009 to December 2011 with a computed tomography angiography (CTA) of diagnostic quality on admission and a discharge diagnosis of stroke or TIA were prospectively included in the cohort.
Upon arrival, all patients underwent physical and neurological examination, and National Institute of Health Stroke Scale (NIHSS) score was obtained along with standard biochemistry, ECG and vital values. All patients underwent non-contrast CT -and in patients without contra indications, CTA was performed. I.V. thrombolysis was administered according to general guidelines. In all non-thrombolysed patients with stroke or TIA, 300 mg of aspirin was administered.
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slice thickness reconstruction). CT angiography was performed from aortic arch to vertex (120 kVp, 295 mAs, collimation 64x0.625mm (isotropic voxel resolution)) with contrast injection, Omnipaque 350 mg/ml, 5 ml/s, monitored by bolus tracking in the descending aorta and scanned with fixed 3 seconds post tracking delay (0.9 mm slice reconstruction).
All images during the study period were reviewed by a consultant neuro-radiologist (AC) blinded to all clinical data using a standardized method. Thoraco-cervicale and intracranial arteries from the aortic arch and cranially were evaluated. An extracranial carotid artery stenosis was considered significant, if a lumen reduction >70% was demonstrated.
All major intracranial vessels (ICA, ACA, MCA, PCA, B and V) were screened for stenosis stratified into three categories of lumen reduction (30-50%, 50-70% and >70%) in accordance to standard WASID criteria for grading of intracranial arterial stenosis [13] . We defined percent stenosis of an intracranial artery as follows:
100, where D(stenosis) = the diameter of the artery at the site of the most severe stenosis and D(normal) = the diameter of the proximal normal artery [13] . If the proximal segment was diseased, contingency sites were chosen to measure D(normal): distal artery (second choice) or feeding artery (third choice). IAS was graded as symptomatic, if supplying a vascular area with radiological signs of acute ischemia and no other obvious cause (e.g. acute occlusion) was present. We employed a semi-quantitative score for the number of vessels calcified according to a presence or absence of calcified foci [12] .
Data Extraction and Definitions:
Data were prospectively collected from all patients on a daily basis from charts and by direct interview. All previous concurrent medical conditions (stroke/TIA, ischemic heart disease, congestive heart failure, periphery artery disease) were confirmed by registrations in previous medical charts. 
Follow-up:
Prior to discharge, all patients with ischemic stroke or TIA were prescribed an antiplatelet treatment regime (clopidogrel -or aspirin and dipyridamol in combination). Patients with diagnosed atrial fibrillation were prescribed oral anti-coagulation treatment, mainly warfarin, but dabigatran was used in some cases. All patients with thrombotic stroke were prescribed a statin and antihypertensives aiming at a maximum systolic value of 130 mmHg.
All patients were followed up after discharge through the national online chart system until 1 st July 2013. Recurrent event was defined as ischemic stroke, TIA or ischemic heart diseases (IHD) as 
Statistics:
No formal sample size calculations were performed. The patient-flow in the study period determined the sample size.
Categorical data were compared among groups using Chi 2 -test. Ordinal or discrete risk factors were represented using median values and compared using Mann-Whitney-U-test. If variables were To assess the association between risk factors and the presence of intracranial atherosclerosis, multi-nominal logistic regression model was used. All risk-factors from table 2 that proved a group difference of p < 0.1 were entered in a backward stepwise multi-nominal logistic regression.
Survival was assessed using Kaplan-Meyer curves. In order to ensure sufficient group size in the Kaplan Meier curves, we grouped 50-70% and >70% stenosis as >50%. Calcifications were grouped into three groups: one without, and two groups with calcifications divided by the total median number of calcified arteries in the cohort. We conducted univariate Cox Proportional
Hazard Model analysis of characteristics in table 2 (not including medical history -prior stroke, TIA or myocardial infarction -due to potential interaction with other characteristics). We transferred characteristics that in the univariate model proved a p < 0.1 to the multivariate model.
Patients lost to follow-up were censured the day they were lost. A general significance level of p < 0.05 was employed. Statistical analysis was performed using SPSS 20 statistical software (IBM Corp., Armonk, NY).
RESULTS:
Study Population:
During the study period, 924 patients were admitted with acute stroke symptoms. The final population thus comprised 652 patients with ischemic stroke or ischemic attack (TIA) ( Figure 1 ).
Only 34 patients (5.2%) had other ethnicity than Scandinavian, of whom 3 (0.5%) of Asian descent. 
Prevalence of Intracranial Atherosclerosis:
A total of 115 IAS were observed in 101 (15.5%) patients (table 1) . 45 (39%) had a severe lumen reduction of >50%. Only one patient underwent endovascular procedures with stenting of a >70% basilar artery stenosis. This patient remained in the cohort due to failure of revascularisation. Three patients had a symptomatic stenosis (all above 50% lumen reduction and all in the MCA). IAC in one or more vessels was observed in 441 (68%) (Figure 2) , and median number of vessels involved was 2. This number was used to group patients with moderate calcifications (1-2 vessels calcified) from patients with extensive lesions (>2 vessels calcified).
Risk Factors:
Based on the baseline characteristics (table 2) , a multi-nominal logistical regression was performed to determine the risk factor profile of IAC and IAS (table 3) . Age was an independent predictor of both IAC and IAS. In addition, atherosclerotic lesions in the aorta and former IHD were independent predictors in both IAC and IAS. Hypertension, former stroke, hypercholesterolemia and extracranial carotid stenosis were independent predictors of IAS (table 3) .
Outcome after Stroke:
Of the 652 patients included in this analysis, 13 were lost to follow-up after hospital discharge -all foreign citizens, who had a stroke while visiting Copenhagen. The median (IQR) follow-up time was 815.5 days (607-1124 days). During the follow-up time, 87 ischemic events were registered (53 strokes, 20 TIA and 14 IHD), and 95 patients died. Kaplan Meier curves for poor outcome (death or ischemic events) are presented in Figure 3 (A+B). A significant difference in risk of poor outcome was present when stratified for the extent of both IAS and IAC (Log Rank test P<0.01 in both A and B). The probability of poor outcome past the first year after index event for patients with no 
DISCUSSION:
In this study, intracranial atherosclerosis was not an unusual finding in North European ischemic stroke and TIA patients. The process of developing atherosclerotic lesions seemed to be part of a global and time-dependent process of atherosclerotic development in the body, marked by progressing age along with accompanying lesions in the aortic arch and former myocardial infarction. In addition, more severe atherosclerotic lesions (lesions with lumen reduction -IAS)
were linked to a more severe risk-profile accompanied by extracranial carotid stenosis as well as traditional stroke risk factors as hypertension and hypercholesterolemia. We furthermore observed that the risk of a poor outcome increased with the burden of intracranial atherosclerotic disease being highest in patients with >50% IAS and >2 vessels IAC. Both IAS (>30%) and IAC-burden were independently associated with risk of recurrent ischemic event.
The primary strength of this study is the high degree of generalizability due to the unselected patient population. This cohort of unselected patients further allows us to compare consecutive stroke or TIA patients with intracranial atherosclerosis against a control group comprised of similar made sure that all patients with permanent stay in Denmark could be followed up, and recurrent events could be assessed from discharge cards. Only patients not seeking medical help for recurrent events have been missed. Another important strength of this study is the consistent use of CTangiography in the population and the blinded standardised imaging evaluation.
The primary limitations of this study are that the true prevalence of intracranial arterial stenosis probably is underestimated due to the acute setting, in which the CTA was performed. IAS may have been mistaken as acute vascular occlusions due to superimposed thrombus. However, in the present study, the aim is to assess the impact of stenosis identified during acute evaluation and their implication and signal value on the prognosis of the patients.
CTA has been shown to process a sensitivity and specificity of 97% and 99.5% respectively in detecting IAS >50% compared to DSA and to be superior to magnetic resonance angiography [15, 16] . A number of studies have used transcranial Doppler to detect stenosis. Although TCD is noninvasive and perform well in the middle cerebral artery, it is highly observer dependent and has poor sensitivity and specificity in the posterior vasculature [17] .
It is known that the prevalence of intracranial atherosclerosis varies with ethnicity. In direct comparison between ethnic groups in the population on Manhattan, persons with Caucasian ancestry have a lower burden of large vessel disease compared to people of Hispanic and AfroAmerican descent [4, 18] . This is supported by studies reporting the prevalence of intracranial artery stenosis to be as high as 30-50% in Asian stroke populations [1, 3, 5, 6 ] and 7-12% in asymptomatic populations [19, 20] . The incidence of documented symptomatic intracranial stenosis The direct comparison of the prevalence of intracranial artery calcification among studies is hampered by differences in the methods of quantifying its extent [11, [24] [25] [26] . However, intracranial artery calcifications are likely to reflect atherosclerotic burden [10, 11] .
Our finding that age is a risk factor for atherosclerotic disease is in accordance with almost all previous studies [2, 11, 19, 24, 26, 27] . It is likely that the process of atherosclerosis in the intracranial vasculatures is of progressive nature and linked to on-going atherosclerotic processes in other body-parts [24, 28, 29] . In this study, we identified hypertension and hypercholesterolemia as risk factors for only intracranial artery stenosis, and not calcifications. This finding is not in accordance with other studies identifying especially hypertension as an important risk-factor for intracranial artery calcifications [26] . However, we believe that the pooling of patients with various degrees of IAC -from patients with one vessel calcified and thus a weak risk-factor profile together with patients with more extensive IAC burden and thus a heavier risk factor profile -may have led to this conclusion.
In the present study, we were not able to identify diabetes as a risk factor for intracranial atherosclerosis. Diabetes is in general believed to be a risk factor for both intracranial artery In order to prevent further ischemic events in patients with intracranial artery stenosis, efforts as balloon angioplasty and stenting have been attempted. The recent SAMMPRIS trial found no benefit of stenting the intracranial stenotic lesions compared to aggressive medical therapy especially due to an unacceptable rate of periprocedural complications [7] . This finding is further supported by results from the WASID-trial proposing that the recurrence rate in patients with symptomatic artery stenosis can be reduced by strict risk-factor modification [33] . This suggests a possible beneficial effect of stricter risk factor control and aggressive medical prophylaxis in patients with lumen-reducing lesions (IAS).
The prognostic value of IAC has only been investigated in a smaller single centre study elaborated by Bugnicourt et al [12] . This study found that IAC provided an independent risk factor for recurrent vascular event and death. This finding is supported by our data and indicates that the burden of IAC should be assessed as a factor in post-stroke risk assessment similar to artery stenosis and atrial fibrillation. To our knowledge, this is the first study to investigate the impact of radiological finding of intracranial atherosclerosis (IAS and IAC) detected during acute evaluation on recurrent vascular events and death in a large well-defined cohort of patients admitted within 4.5 hours of stroke onset.
With the results of the present study in hand, it seems that the problem of preventing recurrent ischemia in patients with intracranial atherosclerosis is still very much alive.
In summary, this study shows that radiological markers of intracranial atherosclerosis are prevalent Atherosclerotic carotid lesions, eGRF and congestive heart failure were entered in the model. Nagelkerke R 2 = 0.40.
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